Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth Thomas

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The British Journal of Nutrition|March 18, 2016
High variation in manufacturer-declared serving size of packaged discretionary foods in AustraliaHila Haskelberg, Bruce Neal, Elizabeth Dunford, et al.
Neoplasia (New York, N.Y.)|January 15, 2010
INCB16562, a JAK1/2 selective inhibitor, is efficacious against multiple myeloma cells and reverses the protective effects of cytokine and stromal cell supportJun Li, Margaret Favata, Jennifer A Kelley, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2018
Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitorChristopher A Luckhurst, Omar Aziz, Vahri Beaumont, et al.
The Journal of Investigative Dermatology|June 17, 2011
Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammationJordan S Fridman, Peggy A Scherle, Robert Collins, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2011
Identification and characterization of INCB9471, an allosteric noncompetitive small-molecule antagonist of C-C chemokine receptor 5 with potent inhibitory activity against monocyte migration and HIV-1 infectionNiu Shin, Kim Solomon, Naiming Zhou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344Carrie M Brodmerkel, Reid Huber, Maryanne Covington, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2010
Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050Jordan S Fridman, Peggy A Scherle, Robert Collins, et al.
Blood|March 4, 2010
Selective inhibition of IDO1 effectively regulates mediators of antitumor immunityXiangdong Liu, Niu Shin, Holly K Koblish, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The British Journal of Nutrition|March 18, 2016
High variation in manufacturer-declared serving size of packaged discretionary foods in AustraliaHila Haskelberg, Bruce Neal, Elizabeth Dunford, et al.
Neoplasia (New York, N.Y.)|January 15, 2010
INCB16562, a JAK1/2 selective inhibitor, is efficacious against multiple myeloma cells and reverses the protective effects of cytokine and stromal cell supportJun Li, Margaret Favata, Jennifer A Kelley, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2018
Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitorChristopher A Luckhurst, Omar Aziz, Vahri Beaumont, et al.
The Journal of Investigative Dermatology|June 17, 2011
Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammationJordan S Fridman, Peggy A Scherle, Robert Collins, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2011
Identification and characterization of INCB9471, an allosteric noncompetitive small-molecule antagonist of C-C chemokine receptor 5 with potent inhibitory activity against monocyte migration and HIV-1 infectionNiu Shin, Kim Solomon, Naiming Zhou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344Carrie M Brodmerkel, Reid Huber, Maryanne Covington, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2010
Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050Jordan S Fridman, Peggy A Scherle, Robert Collins, et al.
Blood|March 4, 2010
Selective inhibition of IDO1 effectively regulates mediators of antitumor immunityXiangdong Liu, Niu Shin, Holly K Koblish, et al.
Pageof 4